CELL INTELLIGENCE · 肿瘤细胞治疗研究

肾细胞癌细胞疗法的演变

Evolution of cell therapy for renal cell carcinoma.

泌尿系统肿瘤中的 NK 细胞与 CAR-NK 细胞治疗：进展、来自 CAR-T 的机制启示及未来方向

Natural killer and CAR-NK cell therapies in urological cancers: Progress, mechanistic lessons from CAR-T, and future directions.

用于透明细胞肾细胞癌的嵌合抗原受体免疫细胞疗法：最新进展与方向

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions.

用白细胞介素-2 重新思考肿瘤治疗策略

Rethinking Oncologic Treatment Strategies with Interleukin-2.

靶向 CD70 的 CAR-T/NK 治疗：原理、进展和未来方向

CD70-targeted CAR-T/NK therapy: Rationale, advances, and future directions.

基于嵌合抗原受体的细胞治疗用于泌尿系统肿瘤

Chimeric antigen receptor-based cell therapy for treating urological tumors.

肾细胞癌细胞治疗的未来

The future of cellular therapy for the treatment of renal cell carcinoma.

迄今为止，过继性细胞治疗取得较大治疗成功的领域包括 CIK 细胞的辅助给药以及抗 CD70 CAR-T 细胞在转移性肾细胞癌患者中的输注。

碳酸酐酶 IX：癌症免疫治疗重新聚焦的靶点

Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy.